Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature’s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases. To learn more visit celularity.com.
Looking for a particular Celularity Inc. employee's phone or email?
The Celularity Inc. annual revenue was $48.2 million in 2026.
Stephen Brigido is the Chairman and CEO of Celularity Inc..
151 people are employed at Celularity Inc..
Celularity Inc. is based in Florham Park, New Jersey.
The NAICS codes for Celularity Inc. are [325, 54, 541, 32, 541714, 54171, 5417].
The SIC codes for Celularity Inc. are [873, 87].